MIRM - Mirum Pharmaceuticals Inc
IEX Last Trade
43.11
1.130 2.621%
Share volume: 331,362
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$41.98
1.13
2.69%
Summary score
9%
Profitability
0%
Dept financing
17%
Liquidity
74%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.87%
Return on assets
-11.48%
Return on sales
-305.71%
Return on invested capital
-157.33%
Total debt ratio
53.36%
Debt ratio change over timeo
-2.16%
Current Ratio
5.6%
Quick Ratio
5.26%
Cash Position Ratio
4.83%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.02%
Return on assets
-4.61%
Return on sales
-50.63%
Return on invested capital
-1003.77%
Total debt ratio
66.62%
Debt ratio change over timeo
-3.75%
Current Ratio
4.98%
Quick Ratio
4.75%
Cash Position Ratio
3.98%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.78%
Return on assets
-4.06%
Return on sales
-38.24%
Return on invested capital
-16.14%
Total debt ratio
64.02%
Debt ratio change over time
-4.09%
Current Ratio
3.68%
Quick Ratio
3.47%
Cash Position Ratio
2.86%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.72%
Return on assets
-87.67%
Return on sales
350.17%
Return on invested capital
-174.49%
Total debt ratio
-215.95%
Debt ratio change over time
-2.16%
Current Ratio
-8.45%
Quick Ratio
-8.63%
Cash Position Ratio
-6.84%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MIRM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.87% | 13.79% | 34.47% | 7.43% |
| Return on assets | -11.48% | 2.76% | 3.15% | 5.62% |
| Return on sales | -305.71% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -157.33% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 53.36% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -2.16% | 308.97% | -6.99% | 1.18% |
| Dept financing | 15% | 50% | 25% | 7% |
| Current Ratio | 4.98% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.75% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.98% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 21% | 48% |
| Short-term ratios | MIRM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -32.02% | 13.77% | 13.25% | 3.8% |
| Return on assets | -4.61% | 2.43% | 1.89% | 3.09% |
| Return on sales | -50.63% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -1003.77% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 66.62% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -3.75% | 46.38% | -72.08% | 1.51% |
| Dept financing | 18% | 50% | 25% | 7% |
| Current Ratio | 4.98% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.75% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.98% | 0.36% | 1.28% | 2.93% |
| Liquididy | 73% | 11% | 28% | 68% |